RVP (Retractable Technologies) ROCE %: -12.92% (As of Mar. 2026)

What is Retractable Technologies ROCE %?

Retractable Technologies RVP +4.82% 37 ROCE % is -12.92% as of Mar. 2026. GuruFocus rates RVP with a GF Score™ of 37/100 and a GF Value™ of $0.77 (Fairly Valued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Retractable Technologies's annualized ROCE % for the quarter that ended in Mar. 2026 was -12.92%.

Retractable Technologies (AMEX:RVP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Retractable Technologies ROCE % Related Terms

Retractable Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for Retractable Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Retractable Technologies ROCE % Chart

Retractable Technologies Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

60.62

3.01

-4.95

-2.11

-8.55

Retractable Technologies Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-27.95	-0.18	1.14	-6.89	-12.92

37GF Score

Retractable Technologies Inc RVP

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Retractable Technologies ROCE % Calculation

Retractable Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-12.186	/	( ( (160.724 - 8.781)	+	(142.63 - 9.598) )	/ 2 )
	=	-12.186	/	( (151.943	+	133.032)	/ 2 )
	=	-12.186	/	142.4875
	=	-8.55 %

Retractable Technologies's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-16.812	/	( ( (142.63 - 9.598)	+	(137.595 - 10.446) )	/ 2 )
	=	-16.812	/	( ( 133.032	+	127.149 )	/ 2 )
	=	-16.812	/	130.0905
	=	-12.92 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -12.92% mean?

Retractable Technologies (RVP) has a ROCE % of -12.92% as of Mar. 2026.

Is Retractable Technologies' ROCE % too high?

Retractable Technologies' current ROCE % is -12.92%. Overall, Retractable Technologies has a GF Score™ of 37/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Retractable Technologies' ROCE % compare to ZJYL and FEMY?

Retractable Technologies' ROCE % of -12.92% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Retractable Technologies's current ROCE % is -12.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Retractable Technologies stock overvalued right now?

Based on GuruFocus' analysis, Retractable Technologies (RVP) is currently considered Fairly Valued. The stock's GF Value™ is $0.77, compared to a current price of $0.72 — trading 6.5% below its estimated fair value. The current ROCE % is -12.92%. Retractable Technologies' overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Retractable Technologies (RVP), the current ROCE % is -12.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Retractable Technologies (RVP) Overvalued in 2026?

Based on GuruFocus' analysis, Retractable Technologies stock appears to be undervalued. The current stock price of $0.72 is trading 6.5% below its estimated GF Value™ of $0.77. GuruFocus considers Retractable Technologies to be Fairly Valued.

Key valuation signals for RVP:

ROCE %: -12.92%
GF Value™: $0.77 vs. price of $0.72 (6.5% below fair value)
GF Score™: 37/100 with 3 warning signs

No single metric tells the full story. See the RVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Retractable Technologies Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies ZJYL FEMY UEEC BNGO HBIO RGNT MHUAF LUCY MLSS CUPR ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Address 511 Lobo Lane, Little Elm, TX, USA, 75068-5295

Website https://www.retractable.com

Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.

37GF Score

Get the complete analysis for RVP

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.72

Price

$0.77

GF Value

View RVP Analysis

See ROCE % data for all stocks →